trending Market Intelligence /marketintelligence/en/news-insights/trending/yfuw2qsuooq3o74hor4tha2 content esgSubNav
In This List

Eloxx Pharmaceuticals appoints director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Eloxx Pharmaceuticals appoints director

Israeli biopharmaceutical company Eloxx Pharmaceuticals Inc. appointed Jasbir Seehra to its board.

Seehra is president and CEO of Keros Therapeutics Inc., a privately owned Lexington, Mass.-based biotech firm.